Insmed (INSM) PT Raised to $33 at Goldman Sachs
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $123.74 -2.05%
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs analyst Graig Suvannavejh raised the price target on Insmed (NASDAQ: INSM) to $33.00 (from $30.00) while maintaining a Buy rating.
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $175 at JPMorgan
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
- H.C. Wainwright Reiterates Buy Rating on Insmed (INSM)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
